SightfileU.S. market data from official filings

Companies › CLRB

CELLECTAR BIOSCIENCES INC (CLRB)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001279704 · EDGAR filings · Updated 2026-07-10

CELLECTAR BIOSCIENCES INC (CLRB) has reported institutional ownership of 7.3%, with 19 institutional managers holding positions valued at $812.9K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
7.3%
Institutional managers
19
Reported 13F value
$812.9K
Insider activity
4 trans.
$124.0K net buying
Data flags
3 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CELLECTAR BIOSCIENCES INC has 19 institutional holders and institutional ownership of 7.3%.

Insider activity

Insiders reported 4 transactions (3 buys, 1 sells) across 4 reporting insiders, with a net reported value of $124.0K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2020-03-09) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-01-31 (recurring since 2021-11-02) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2024-08-09 (recurring since 2024-08-09) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BioCardia Inc (BCDA) · INTENSITY THERAPEUTICS INC (INTS) · Phio Pharmaceuticals Corp (PHIO) · ABVC BIOPHARMA INC (ABVC) · Cocrystal Pharma Inc (COCP) · ERNEXA THERAPEUTICS INC (ERNA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.